Ironwood Pharmaceuticals | IRWD - Interest Expense On Debt



Ironwood Pharmaceuticals reported $8.74M in Interest Expense on Debt for its fiscal quarter ending in December of 2024.


Interest Expense On Debt Change Date
Acadia Pharmaceuticals 0 4.12M Sep/2024
Agios Pharmaceuticals 3.01M 10.05M Dec/2024
Alnylam Pharmaceuticals USD 40.25M 1.6M Jun/2025
Amarin USD 3K 3K Dec/2024
Ardelyx USD 6.58M 2.61M Jun/2025
Astellas Pharma 3.91B 320M Mar/2025
AstraZeneca 303M 126M Jun/2025
Charles River Laboratories USD 29.97M 2.08M Jun/2025
Exact Sciences USD 9.83M 143K Jun/2025
Halozyme Therapeutics USD 4.39M 131K Jun/2025
Incyte USD 594K 66K Jun/2025
Ironwood Pharmaceuticals USD 8.74M 506K Dec/2024
MacroGenics USD 802K 826K Jun/2025
Moderna USD 1000K 0 Jun/2025
Myriad Genetics USD 800K 100K Mar/2025
Pacira USD 3.82M 110K Jun/2025
PTC Therapeutics USD 30.36M 4.03M Jun/2025
Sarepta Therapeutics USD 5.23M 725K Jun/2025
Takeda 107.16B 56.83B Jun/2025
Ultragenyx Pharmaceutical 14.04M 1.48M Jun/2025